Personalized Medicine
45 articles
The Promise of Organoids
Dr. Brian Wolpin explains how organoids are being used to develop personalized treatment for pancreatic cancer patients.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Report Highlights Potential of TCR Therapy
Read about the potential of TCR therapy, a technique used with success for one pancreatic cancer patient in a groundbreaking immunotherapy clinical trial.
New Study to Get More Minorities Involved in Genetic Testing
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
Representing Genetic and Clinical Diversity in Pancreatic Cancer
Dr. Kentaro Sudo explores the possible causes for different responses to drugs among ethnic groups, pointing to the need for clinical diversity in trials.
An Interview with Dr. Tyler Jacks
Dr. Tyler Jacks is one of the leading pancreatic cancer researchers. Read what he has to say about KRAS, organoids, and running a lab in a pandemic.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Finding a Treatment Geared to My Cancer
Samuel Chi describes his search for a pancreatic cancer treatment that allows him to live comfortably and reduce his tumor so he can have surgery.
Thriving After Surviving Pancreatic Cancer
Nancy Nebenzahl, a sever-year survivor of pancreatic cancer, had a Whipple and a personalized treatment plan. She supplemented this with acupuncture and exercise to ease the side effects.
Looking Back and Looking Forward
For Let’s Win’s 10th anniversary, long-term survivor Roberta Luna looks back at the changes and forward to future gains.
Integrative Oncology Explained
Dr. Santosh Rao believes in the value of integrative oncology, which treats the whole person, not just the patient.
Kerri Kaplan
Kerri Kaplan is the President of the Lustgarten Foundation, which is America’s largest private funder of pancreatic cancer research and is relentlessly focused on improving patient outcomes. Kerri oversees all aspects of the Lustgarten Foundation’s operational activities, including major fundraising initiatives, patient outreach, and the Foundation’s in-depth research portfolio. Early in her career at the […]